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in Primary Ciliary Dyskinesia 
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 Kenneth N.  Olivier ,  MD ;  Scott D.  Sagel ,  MD ;  Carlos  Milla ,  MD ;  Maimoona A.  Zariwala ,  PhD ;  Whitney  Wolf ,  BS ; 
 Johnny L.  Carson ,  PhD ;  Milan J.  Hazucha ,  MD ,  PhD ;  Kimberlie  Burns ;  Blair  Robinson ,  MD ;  Michael R.  Knowles ,  MD ; 
and  Margaret W.  Leigh ,  MD ;  on behalf of the Genetic Disorders of Mucociliary Clearance Consortium 
 BACKGROUND:  Motile cilia dysfunction causes primary ciliary dyskinesia (PCD), situs inver-
sus totalis (SI), and a spectrum of laterality defects, yet the prevalence of laterality defects other 
than SI in PCD has not been prospectively studied. 
 METHODS:  In this prospective study, participants with suspected PCD were referred to our 
multisite consortium. We measured nasal nitric oxide (nNO) level, examined cilia with electron 
microscopy, and analyzed PCD-causing gene mutations. Situs was classifi ed as (1) situs solitus 
(SS), (2) SI, or (3) situs ambiguus (SA), including heterotaxy. Participants with hallmark electron 
microscopic defects, biallelic gene mutations, or both were considered to have classic PCD. 
 RESULTS:  Of 767 participants (median age, 8.1 years, range, 0.1-58 years), classic PCD was 
defi ned in 305, including 143 (46.9%), 125 (41.0%), and 37 (12.1%) with SS, SI, and SA, respec-
tively. A spectrum of laterality defects was identifi ed with classic PCD, including 2.6% and 
2.3% with SA plus complex or simple cardiac defects, respectively; 4.6% with SA but no cardiac 
defect; and 2.6% with an isolated possible laterality defect. Participants with SA and classic 
PCD had a higher prevalence of PCD-associated respiratory symptoms vs SA control partici-
pants (year-round wet cough,  P  , .001; year-round nasal congestion,  P  5 .015; neonatal respi-
ratory distress,  P  5 .009; digital clubbing,  P  5 .021) and lower nNO levels (median, 12 nL/min 
vs 252 nL/min;  P  , .001). 
 CONCLUSIONS:  At least 12.1% of patients with classic PCD have SA and laterality defects 
ranging from classic heterotaxy to subtle laterality defects. Specifi c clinical features of PCD and 
low nNO levels help to identify PCD in patients with laterality defects. 
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 ABBREVIATIONS:  CA  5 central apparatus; d-TGA  5 dextro-transposition 
of the great arteries; EM  5 electron microscopic; IDA  5 inner dynein 
arm; nNO  5 nasal nitric oxide; ODA  5 outer dynein arm; PCD  5 primary 
ciliary dyskinesia; SA  5 situs ambiguus; SI  5 situs inversus totalis; 
SS  5 situs solitus 
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 Primary ciliary dyskinesia (PCD) is a rare autosomal 
recessive disease with an estimated prevalence of one in 
16,000. 1,2 Patients with PCD display neonatal respiratory 
distress, chronic sinopulmonary disease, bronchiectasis, 
recurrent otitis media, and infertility. 3 Situs inversus 
totalis (SI), or mirror-image organ arrangement, occurs 
in slightly  , 50% of patients with PCD; however, a sub-
set of patients with PCD have organ laterality defects 
that do not meet a classic defi nition of SI. Instead, fi nd-
ings in this subset of patients correspond to an interme-
diate classifi cation defi ned as situs ambiguus (SA) with a 
spectrum of organ laterality defects. Classifi cation of 
these defects is complicated because diff erent specialists 
tend to use diff erent defi nitions for SA and heterotaxy. 4-8 
Some clinicians interchange the terms “situs ambiguus” 
and “heterotaxy”; however, cardiologists defi ne hetero-
taxy as a subset of SA with specifi c congenital heart 
defects (eg, common atrium, levo-transposition of great 
arteries). Geneticists have expanded the cardiology defi -
nition to include combinations of abdominal defects 
(eg, asplenia, polysplenia) or vascular defects (eg, inter-
rupted inferior vena cava). Despite this confusion, pre-
vious studies of heterotaxy reported a prevalence of one 
in 10,000, with multimodal forms of inheritance. 9,10 We 
defi ne in this article any laterality defect other than SI as 
 Materials and Methods 
 Th rough our multicenter Genetic Diseases of Mucociliary Clearance 
Consortium, symptomatic adults and children were referred for pre-
viously diagnosed or suspected PCD. Medical records were reviewed 
and evaluations conducted at one of seven sites in California, Colorado, 
Maryland, Missouri, North Carolina, Washington, and Ontario, Canada, 
between May 2006 and September 2012. 
 Initial situs status was determined by physicians at local consortium 
sites through review of radiology, surgery, and cardiology reports and 
radiology images from participant medical records. Additionally, stan-
dardized questions to detect situs anomalies were asked of each partic-
ipant. One consortium physician (A. J. S.) reviewed each potential SA 
case in a nonblinded fashion, verifying the situs lesions through source 
documentation before assigning the ultimate situs designation. Partic-
ipants were grouped into one of the following situs categories: (1) situs 
solitus (SS); (2) SI; or (3) SA, which includes heterotaxy ( Fig 1 ). Next, 
we used the congenital heart disease classifi cation schema developed by 
Botto et al 18 to assign participants with SA to one of the following SA 
subgroups: (1) SA with complex cardiovascular malformation (heterotaxy 
to most cardiologists), including cardiac isomerism or any cardiovascu-
lar defect or groups of defects that do not fi t into standard cardiac phe-
notype classifi cation or associations; (2) SA with simple cardiovascular 
malformation, including cardiovascular malformations within stan-
dard cardiac phenotype classifi cation or associations; (3) SA without 
cardiac malformation, including vascular, abdominal, or laterality defects 
but normal cardiac status; and (4) isolated possible laterality defect con-
sisting of one solitary defect, possibly related to issues of laterality, in 
either cardiac or noncardiac systems. Laterality defects included in each 
group are detailed in  Table 1 . 
 Nasal nitric oxide (nNO) level was measured in participants with either 
a CLD 88 series (Eco Medics AG), a NIOX Flex (Aerocrine), or a Sievers 
Leigh), University of North Carolina School of Medicine, Chapel 
Hill, NC. 
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SA and only those with SA combined with complex 
heart lesions as heterotaxy. 
 Studies have demonstrated that cilia dysfunction in 
embryonic nodal plate cells results in laterality defects 
and congenital heart disease. 11,12 In addition, a link between 
embryonic cilia dysfunction and respiratory cilia dys-
function in mice demonstrates that mutations in  Dnai2 
FOR EDITORIAL COMMENT SEE PAGE  1136 
and  Dnahc5 (homologs to  DNAI2 and  DNAH5 in 
humans) lead to heterotaxy and PCD with outer dynein 
arm (ODA) defects. 13,14 Kennedy et al 15 demonstrated 
retrospectively that SA anomalies and heterotaxy are 
present in at least 6.3% of an international PCD popula-
tion. Most patients with SA, particularly those with con-
genital heart disease, have complicated medical courses, 
including neonatal respiratory distress, cyanosis, and 
pneumonia. Th ese respiratory manifestations are com-
monly attributed to a cardiac origin without consider-
ation of possible respiratory cilia dysfunction. 16,17 Th e 
present prospective study examined the prevalence of 
laterality defects other than SI in a PCD population and 
determined which clinical and diagnostic characteristics 
suggest PCD in a population with complex situs issues. 
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 Figure 1 – Examples of laterality defects on radiology imaging in various situs groups in the study population. A, A participant with situs solitus, or 
normal organ arrangement, with left  cardiac apex, left -sided stomach bubble, and right-sided liver. B, A patient with situs inversus totalis, or mirror-
image organ arrangement, with right-sided cardiac apex, right-sided stomach bubble, and left -sided liver. C, A patient with situs ambiguus with left -
sided cardiac apex, right-sided stomach bubble, right-sided liver, and intestinal malrotation who also has right-sided polysplenia visualized on CT scan. 
C  5 cardiac apex; L  5 liver; M  5 intestinal malrotation; S  5 stomach . 
NOA 280i (General Electric Company) chemiluminescence analyzer, 
using standard operating procedures. In participants who could cooper-
ate with standard velum closure maneuvers (generally aged  . 5 years), 
values were obtained during a 5-s plateau while exhaling through a 
resistor. 19,20 Reported values are the mean of three maneuvers each in 
the left - and right-side naris. Otherwise, nNO values were obtained 
during tidal breathing, using the mean of the fi ve highest tidal peaks 
from each naris. 21 Measured nNO concentration was multiplied by sam-
pling fl ow to determine nNO production in nanoliters per minute. For 
velum closure nNO and tidal breathing nNO, values  , 77 nL/min 20,22,23 
and  , 40 nL/min, 21,24 respectively, were considered low and within PCD 
range. Velum closure nNO measurements were also collected from 
77 healthy pediatric control participants. 
 Nasal ciliary biopsy specimens were processed for ultrastructural anal-
ysis through transmission electron microscopy (Zeiss EM900; Carl 
Zeiss AG). Photomicrographs were reviewed in a blinded fashion by 
three independent observers. Each reviewer separately determined 
whether hallmark disease-causing defects were present in the ODAs, 
inner dynein arms (IDAs), or central apparatus (CA). 3,25,26 Genetic test-
ing for known mutations in PCD-causing genes was performed in cases 
with hallmark electron microscopic (EM) defects and strong clinical 
phenotypes. We tested  DNAI1 and  DNAH5 for patients with ODA 
defects;  DNAAF2 ,  DYX1C1 ,  HEATR2 , and  LRRC6 for patients with 
ODA plus IDA defects;  CCDC39 and  CCDC40 for patients with IDA 
plus CA and microtubule disorganization defects;  DNAH11 for patients 
with normal ciliary ultrastructure; and all of these genes in patients 
where ciliary ultrastructure was not available. Both EM and genetic 
testing were performed in centralized laboratories at the University of 
North Carolina using standard operating procedures. 
 Participants with biallelic mutations in PCD-causing genes, hallmark 
EM defects, or both were given a diagnosis of classic PCD. All remain-
ing participants were labeled as without classic PCD and grouped 
 TABLE 1  ]  Laterality Defects Included in SA Subgroups 
SA  1 Complex CVM (Heterotaxy ) SA  1 Simple CVM SA Without Cardiac
Isolated Possible 
Laterality Defect
SA plus any of the following 
  cardiac issues:
 • Cardiac isomerism
 • Hypoplastic ventricle with 
  other cardiac lesions 
(except ASD or APVR alone)
 • l-TGA  1 LVOTO (PS)
 • Any defects that do not 
  fi t into a standard cardiac 
phenotype classifi cation or 
standard associations
SA plus any of the 








 • Common atrium
 • Tetralogy of Fallot
 • Pulmonary stenosis 
   or atresia
 • Overriding aorta
 • DORV
 • Ebstein anomaly
 • Tricuspid atresia
 • l-TGA
 • Truncus defect
 • HLHS  1 VSD/APVR
SA including any of the 
   following defects:
Vascular
 • APVR
 • Right aortic arch
 • Bilateral or left superior 
   vena cava
 • Interrupted or duplicated 
   inferior vena cava
Abdomen
 • Asplenia or polysplenia
 • Intestinal malrotation
 • Midline liver
 • Left-sided liver
 • Right-sided spleen or 
   stomach
Pulmonary
 • Left- or right-side 
   pulmonary isomerism
Any solitary lesion that 
  may be associated 
with laterality defects, 
including cardiac or 
noncardiac lesions
 Classifi cation criteria used from Botto et al. 18 APVR  5 anomalous pulmonary venous return; ASD  5 atrial septal defect; AVSD  5 atrioventricular septal 
defect; CVM  5 cardiovascular malformation; DORV  5 double-outlet right ventricle; HLHS  5 hypoplastic left heart syndrome; l-TGA  5 levo-transposition 
of the great arteries; LVOTO  5 left ventricular outfl ow tract obstruction; PS  5 pulmonary stenosis; SA  5 situs ambiguus; VSD  5 ventricular septal 
defect. 
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according to normal or low nNO levels. Th ose with normal nNO 
levels above our cutoff formed the SA control group. Final data ana-
lyses were limited to participants aged  . 1 year in whom nNO mea-
surements were more reliable and adequate clinical symptom history 
had been established. Continuous data and categorical data were 
analyzed using Wilcoxon rank sum and  x 2 or Fisher exact tests, respec-
tively. Multiple group comparisons were performed using Kruskal-
Wallis test. Statistical signifi cance was defi ned as  P  , .05 for two-way 
comparisons and as  P   .03 with Bonferroni correction for post hoc 
comparisons of multiple groups against classic PCD. Institutional 
review boards at the participating institutions approved this protocol 
(e-Appendix 1). 
 Results 
 Overall, 305 of 767 participants (39.8%) were given a 
diagnosis of classic PCD, including 37 (12.1%) with SA 
and classic PCD. Th is group with SA and classic PCD 
included eight with SA plus complex cardiovascular 
malformation, seven with SA plus simple cardiovascular 
malformation, 14 with SA without cardiac malformation, 
and eight with a possible isolated laterality defect ( Fig 2 , 
e-Table 1). SA was identifi ed in 41 of 462 participants 
without classic PCD. Twenty-fi ve of these participants 
had normal nNO levels above our cutoff  and formed the 
SA control group. Nine participants with SA without 
classic PCD had low nNO levels under our cutoff , and 
seven others were not included in the fi nal data analysis 
because they were aged  , 1 year. Th e median age of 
participants with SA and classic PCD was signifi cantly 
greater than that of participants in the SA control group 
( Table 2 ). No specifi c organ laterality defects were more 
prevalent in classic PCD; however, dextro-transposition 
of the great arteries (d-TGA ) was more prevalent in SA 
without classic PCD than in classic PCD. Asplenia and 
atrioventricular septal defect were more prevalent in SA 
without classic PCD and nNO levels below our cutoff  
than in classic PCD ( Table 2 ). Nine participants with SA 
and classic PCD also had siblings enrolled in the proto-
col, but none of the siblings had SA. 
 Nineteen of the 37 participants (51%) with SA and 
classic PCD had ODA defects alone on electron micros-
copy; eight (22%) had ODA plus IDA defects; fi ve 
(13%) had IDA plus CA and microtubule disorganiza-
tion defects; four (11%) had inadequate or indetermi-
nate (no hallmark PCD-causing defects, but not normal 
either) samples; one (3%) had normal EM fi ndings; 
and none had isolated CA, IDA, or radial spoke defects. 
Distribution of ODA defects, ODA plus IDA defects, 
and IDA plus CA and microtubule disorganization 
defects in SA was similar to that in SS and SI. None 
of the participants who had radial spoke defects had 
laterality defects. There were no significant correla-
tions between genetic mutation and situs anomalies. 
Distri bution of EM defects within the SA population 
did not correspond to specifi c laterality defects 
( Table 3 ). 
 Year-round wet cough, year-round nasal congestion, 
neonatal respiratory distress, and digital clubbing were 
signifi cantly more prevalent in participants with classic 
PCD than in SA control participants ( Table 4 ). Th e 
prevalence of digital clubbing did not correlate with 
participant age (median age with clubbing, 14 years; 
median age with no clubbing, 8.5 years;  P  5 .19). Th e 
prevalence of neonatal respiratory distress in classic 
PCD was increased despite a higher prevalence of con-
genital heart disease, which is known to cause respira-
tory distress, in SA control participants. Th e age of onset 
for nasal congestion was signifi cantly earlier in classic 
PCD, but age of onset for other sino-oto-pulmonary 
symptoms was similar in both groups and mainly within 
the fi rst year of life ( Table 4 ). 
 Levels of nNO measured during velum closure were 
signifi cantly lower in participants with classic PCD 
(median, 12 nL/min; range, 4-48 nL/min; n  5 30) than 
in all participants without classic PCD (median nNO 
level above cutoff , 252 nL/min [range, 137-338 nL/min; 
n  5 11]; median nNO level below cutoff , 29 nL/min 
[range 8-66, n  5 8];  P  , .001). Levels of nNO during 
tidal breathing were also signifi cantly lower in partici-
pants with classic PCD (median, 8.5 nL/min; range, 
5-16 nL/min; n  5 4) than in those without classic PCD 
(median, 128 nL/min; range, 37-276; n  5 14;  P  5 .003). 
For the 77 healthy control participants, median velum 
closure nNO level was 286 nL/min, which was signifi -
cantly higher than in participants with classic PCD 
 Figure 2 – Distribution of participants across laterality defect groups and 
situs ambiguus subgroups. CVM  5 cardiovascular malformation, 
EM  5 electron microscopic; nNO  5 nasal nitric oxide; PCD  5 primary 
ciliary dyskinesia. 
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 TABLE 2  ]  Demographics of Participants With SA Aged  . 1 Year 
Demographic or Laterality Defect Classic PCD (n  5 35)
Not Classic PCD, nNO 
Above Cutoff  a (SA Control 
Group) (n  5 25)
Not Classic PCD, nNO 
Below Cutoff  a (n  5 9)  P Value b 
Age, y 12.4 (1.8-58) 5.6 (1.2-39) 8.0 (6.5-26) .003 c 
Male sex 34 56 56 .20
White race 80 83 78 .92
Chest radiograph for review 100 92 100 .17
CT/MRI scan chest for review 91 72 89 .13
Abdominal CT or ultrasound scan 
for review
89 76 89 .41
Echocardiogram for review 80 92 100 .18
Any congenital heart disease 49 68 78 .15
Classic heterotaxic heart defect 20 20 44 .31
Atrial situs inversus 26 32 22 .80
Common atrium 0 4 0 .41
Dextrocardia 46 50 33 .31
AVSD 9 8 44 .01 d 
ASD 20 32 22 .56
VSD 26 40 0 .07
Single ventricle 9 12 11 .91
Double-outlet right ventricle 14 4 22 .26
Pulmonary stenosis or atresia 11 32 33 .11
Dextro-transposition of great arteries 3 24 11 .04 e 
l-TGA 11 8 22 .46
Bilateral superior vena cava 6 21 11 .21
Right aortic arch 46 36 56 .56
Interrupted/duplicated inferior 
vena cava
34 39 22 .66
APVR 11 12 33 .23
Intestinal malrotation 24 21 44 .36
Dextrogastria 65 52 44 .56
Midline liver 21 21 33 .70
Asplenia 6 11 43 .03 f 
Polysplenia 55 53 43 .85
 Data are presented as median (range) or %. nNO  5 nasal nitric oxide; PCD  5 primary ciliary dyskinesia. See  Table 1 legend for expansion of other 
abbreviation. 
 a Velum closure nNO cutoff   5 77 nL/min; tidal breathing nNO cutoff   5 40 nL/min. 
 b x 2 test among three categorical groups. 
 c Kruskal-Wallis test for median age three-group comparison. Median age of classic PCD vs SA control group Wilcoxon  P  5 .002; median age of classic 
PCD vs not classic PCD, nNO below cutoff ,  P  5 .12. 
 d AVSD in classic PCD vs SA control group Fisher exact  P  5 .65; in classic PCD vs not classic PCD, nNO below cutoff ,  P  5 .02. 
 e Dextro-transposition of the great arteries in classic PCD vs SA control group Fisher exact  P  5 .02; in classic PCD vs not classic PCD, nNO below cutoff , 
 P  5 .38. 
 f Asplenia in classic PCD vs SA control group Fisher exact  P  5 .49; in classic PCD vs not classic PCD, nNO below cutoff ,  P  5 .03. 
and SA control participants (range healthy control 
participants, 125-867 nL/min; Kruskal-Wallis  P  , .001) 
( Fig 3 ). Th ere were no signifi cant diff erences in velum 
closure nNO levels among the SA subgroups with classic 
PCD (Kruskal-Wallis  P  5 .30) ( Fig 4 ). 
 Discussion 
 SI has been associated with PCD since the fi rst case 
reports; however, SA with PCD has received attention 
only recently. 15,16,27,28 Th is study reveals that the preva-
lence of SA (including heterotaxy) in a cohort of patients 
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 TABLE 3  ]  Diagnostic Testing of Participants With Classic PCD and SA 
ID Age, y nNO, nL/min Situs EM Defect Biallelic Mutation a 
PCD1 0.1 b 8.79 c SA  1 complex CVM ODA  1 IDA  HEATR2 
PCD2 0.2 b 11.2 c SA  1 simple CVM ODA  1 IDA …
PCD3 1.8 16.1 c SA  1 complex CVM ODA …
PCD4 3.0 4.6 c SA  1 complex CVM Indeterminate  DNAH5 
PCD5 4.7 6.1 c SA  1 simple CVM ODA …
PCD6 7.8 10.9 c SA without cardiac defect Indeterminate  CCDC39 
PCD7 5.2 4.3 SA  1 complex CVM Inadequate sample  DNAH5 
PCD8 6.4 Not done SA without cardiac defect ODA  DNAH5 
PCD9 7.3 6.8 SA  1 simple CVM IDA  1 CA, MTD  CCDC40 
PCD10 7.4 5.7 SA  1 complex CVM ODA  DNAH5 
PCD11 8.1 22.0 SA without cardiac defect ODA …
PCD12 8.1 10.4 SA  1 simple CVM ODA  1 IDA  DYX1C1 
PCD13 8.5 9.6 SA  1 simple CVM IDA  1 CA, MTD  CCDC40 
PCD14 9.3 10.0 SA without cardiac defect ODA …
PCD15 10.7 35.7 SA  1 simple CVM ODA  DNAH5 
PCD16 11.1 25.6 SA without cardiac defect ODA  1 IDA …
PCD17 11.2 9.8 SA without cardiac defect IDA  1 CA, MTD …
PCD18 11.4 10.2 Isolated possible laterality defect ODA  1 IDA  KTU 
PCD19 11.5 13.2 SA  1 complex CVM ODA  DNAI1 
PCD20 12.4 25.5 SA  1 complex CVM Normal  DNAH11 
PCD21 12.9 8.9 SA  1 complex CVM Inadequate sample  DNAH5 
PCD22 13.4 20.7 Isolated possible laterality defect ODA  1 IDA defects  HEATR2 
PCD23 14.0 32.5 Isolated possible laterality defect ODA defect  DNAH5 
PCD24 15.6 35.8 SA without cardiac defect ODA defect  DNAH5 
PCD25 16.0 11.9 Isolated possible laterality defect IDA  1 CA, MTD …
PCD26 16.9 16.5 SA without cardiac defect ODA …
PCD27 18.6 26.4 Isolated possible laterality defect ODA  DNAH5 
PCD28 20.5 29.9 SA  1 simple CVM ODA …
PCD29 22.7 5.5 Isolated possible laterality defect IDA  1 CA, MTD …
PCD30 24.6 35.7 Isolated possible laterality defect ODA  DNAH5 
PCD31 30.7 5.8 SA without cardiac defect ODA …
PCD32 31.7 13.1 SA without cardiac defect ODA 1 IDA  LRRC6 
PCD33 34.7 47.6 SA without cardiac defect ODA  DNAH5 
PCD34 35.8 43.7 SA without cardiac defect ODA …
PCD35 45.8 12.1 SA without cardiac defect ODA  DNAH5 
PCD36 55.2 5.7 Isolated possible laterality defect ODA  DNAH5 
PCD37 58.0 7.2 SA without cardiac defect ODA  1 IDA …
 CA  5 central apparatus; IDA  5 inner dynein arm; ODA  5 outer dynein arm; MTD  5 microtubule disorganization. See  Table 1 and 2 legends for 
expansion of other abbreviations. 
 a Ellipses denote no genetic mutations isolated. We tested  DNAI1 and  DNAH5 for patients with ODA defects;  DNAAF2 ,  DYX1C1 ,  HEATR2 , and  LRRC6 for 
patients with ODA  1 IDA defects;  CCDC39 and  CCDC40 for patients with IDA  1 CA and MTD defects;  DNAH11 for patients with normal ciliary 
ultrastructure; and all of these genes for patients in whom ciliary ultrastructure was not available. 
 b Participants aged  , 1 y not included in data analysis. 
 c nNO values obtained with the tidal breathing technique. 
 1182  Original Research  [   1 4 6  #  5   C H E S T   N OV E M B E R   2 0 1 4   ] 
 TABLE 4  ]  Clinical Features of Participants With SA Aged  . 1 Year 
Clinical Feature Classic PCD (n  5 35)
Not Classic PCD nNO 
Above Cutoff  a (SA Control 
Group) (n  5 25)
Not Classic PCD nNO 
Below Cutoff  a (n  5 9)  P Value b 
Respiratory symptom
 Year-round wet cough 34 of 35 (97) 9 of 21 (43) 7 of 9 (78)  , .001 c 
 Year-round nasal congestion 33 of 35 (94) 16 of 23 (70) 6 of 8 (75) .05 d 
 Digital clubbing 7 of 33 (21) 0 of 22 (0) 1 of 8 (13) .07 e 
 NRD f 24 of 29 (83) 8 of 19 (42) 6 of 6 (100) .001 g 
 Heart disease known to cause NRD 15 of 28 (54) 13 of 19 (68) 5 of 7 (71) .38
 Chronic otitis media 30 of 34 (88) 18 of 23 (78) 7 of 9 (78) .58
 Sinusitis 24 of 34 (71) 18 of 22 (82) 6 of 8 (75) .59
 Pneumonia/bronchitis 27 of 35 (77) 18 of 22 (82) 8 of 8 (100) .32
Age of onset for respiratory symptom
 Year-round wet cough 0.08 (0.08-13) 0.59 (0.08-4) 0.33 (0.08-3) .81
 Year-round nasal congestion 0.08 (0.08-11) 0.42 (0.08-15) 1 (0.08-2) .07 h 
 First episode otitis media 0.42 (0.08-5) 0.29 (0.08-8) 0.5 (0.25-23) .98
 Data are presented as No. of total No. (%) participants with indicated respiratory symptom or median age in y (range). NRD  5 neonatal respiratory 
disease. See  Table 1 and 2 legends for expansion of other abbreviations. 
 a Velum closure nNO cutoff   5 77 nL/min; tidal breathing nNO cutoff   5 40 nL/min. 
 b x 2 test among three groups. 
 c Cough in classic PCD vs SA control group Fisher exact  P  , .001; in classic PCD vs not classic PCD, nNO below cutoff ,  P  5 .10. 
 d Nasal congestion in classic PCD vs SA control group Fisher exact  P  5 .015; in classic PCD vs not classic PCD, nNO below cutoff ,  P  5 .15. 
 e Clubbing in classic PCD vs SA control group Fisher exact  P  5 .021; in classic PCD vs not classic PCD, nNO below cutoff ,  P  5 .50. 
 f Not attributable to preterm birth or meconium aspiration. 
 g NRD in classic PCD vs SA control group Fisher exact  P  5 .009; in classic PCD vs not classic PCD, nNO below cutoff ,  P  5 .37. 
 h Age of onset for nasal congestion in classic PCD vs SA control group Wilcoxon  P  5 .026; in classic PCD vs not classic PCD, nNO below cutoff ,  P  5 .44. 
with classic PCD is 12.1%, and this increases to 12.8% 
when excluding radial spoke and CA defects from an 
overall PCD denominator because these defects are not 
present in embryonic nodal cilia and, thus, do not pre-
sent with heterotaxy. PCD is diagnosed in patients with 
various combinations of laterality defects, including simple 
and complex heart disease and combinations of noncar-
diac laterality defects, which do not fi t into standard 
defi nitions of heterotaxy. Moreover, collections of later-
ality defects in some patients with SA do not correspond 
to the phenotypes of left  or right isomerism , which oft en 
are used to group laterality defects clinically. Th e par-
ticipants with confi rmed PCD and SA without classic 
heterotaxic heart defects or isomerism sequence may 
 Figure 3 – Measurements of nNO in 
participants by fi nal diagnosis group. 
Shown are nNO values by velum 
closure in participants with SA. Box 
plots show interquartile range, with 
median denoted by bold line. Whiskers 
denote minimum to maximum values. 
See Figure 2 legend for expansion of 
abbreviations. 
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represent a variant form of heterotaxy that is not fully 
appreciated. 9,29,30 Genetic defects known to cause classic 
heterotaxy can also cause isolated d-TGA or double-outlet 
right ventricle, which in isolation are not considered 
heterotaxy by many cardiologists. 31 Furthermore, isolated 
cardiac septal defects have been linked to ciliary genes. 32 
Th us, a wide spectrum of laterality defects may be attrib-
utable to ciliary dysfunction and associated with PCD. 
 Th e SA prevalence within the present PCD population is 
nearly twice that reported in the Kennedy et al 15 study. 
Although our subclassifi cation schema for SA was dif-
ferent from that of Kennedy et al, 15 our defi nition of PCD 
and overall defi nition of laterality and cardiac defects 
comprising SA were similar. Th e increased prevalence 
in the present study may be due to heightened aware-
ness of the link between heterotaxy and PCD, leading 
to increased referral patterns. Additionally, our use of 
standardized questions on laterality and cardiovascular 
anomalies within this prospective protocol may have 
been more attuned to the discovery of laterality defects 
than the retrospective protocol of Kennedy et al. 15 
 No specifi c laterality defects were more prevalent in par-
ticipants with classic PCD than in SA control participants. 
d-TGA was signifi cantly more prevalent in SA control 
participants with normal nNO levels, yet one participant 
with d-TGA had classic PCD. Asplenia and atrioventric-
ular septal defect, which oft en are seen together in right 
isomerism, were more prevalent in those without classic 
PCD and nNO levels below our cutoff . It is possible that 
these individuals carry an undiscovered PCD genetic 
mutation associated with right isomerism and normal 
fi ndings on electron microscopy. Perhaps with larger SA 
populations, one could fi nd certain laterality defects 
associated with classic PCD. 
 Clinical symptom assessment in this SA population 
demonstrates that year-round wet cough and year-
round nasal congestion were signifi cantly more preva-
lent in participants with classic PCD than in SA control 
participants. Although one would expect a large propor-
tion of patients with SA to have neonatal respiratory 
distress due to an increased burden of congenital heart 
disease, the prevalence of neonatal respiratory distress 
in participants with classic PCD was signifi cantly more 
than in SA control participants. Th erefore, in patients 
with forms of SA sparing the heart or with neonatal 
respiratory distress out of proportion with their cardiac 
defect, one should suspect possible PCD. Finally, digital 
clubbing was signifi cantly more prevalent in partici-
pants with classic PCD than in SA control participants, 
even though clubbing is commonly found in patients 
with cyanotic congenital heart disease. 33 
 nNO is a useful test for PCD screening, but this has not 
been broadly studied in patients with SA. We saw signif-
icantly lower nNO levels in participants with SA and 
classic PCD than in SA control participants. All partici-
pants with SA and classic PCD had nNO levels below 
the previously established PCD cutoff  of 77 nL/min. 20 
Levels of nNO did not vary greatly among SA subgroups 
with classic PCD, which further supports the concept of 
SA as a spectrum of laterality defects with similar respi-
ratory ciliary dysfunction regardless of the SA defects. A 
substantial number of participants had some features 
 Figure 4 – Measurements of nNO in SA subgroups with classic primary cilia dyskinesia. Shown are nNO values by velum closure in participants with 
SA according to SA subgroup. Box plots show interquartile range, with median denoted by bold line. Whiskers denote minimum to maximum values. 
SA  5 situs ambiguus. See  Figure 2 legend for expansion of other abbreviations. 
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suggestive of PCD with nNO levels below our cutoff  
value; however, they did not meet our criteria for classic 
PCD. With further genetic discovery, some of these may 
ultimately be defi ned as PCD. Until a full spectrum of 
PCD gene mutations is defi ned, clinicians may encoun-
ter patients with some clinical features of PCD and low 
nNO levels who do not fulfi ll classic defi nitions of PCD, 
as we saw here. 
 Th ere are several limitations to this study. First, there is 
no universally accepted defi nition of heterotaxy or SA. 
Th erefore, we used a classifi cation schema that delin-
eates patients with simple or complex heterotaxic heart 
defects, who oft en are followed by cardiologists, from 
others with noncardiac laterality defects and isolated 
possible laterality defects, who oft en are followed out-
side of cardiology. Some patients with SS or SI in our 
protocol did not have complete abdominal imaging. 
Consequently, some abdominal laterality defects may 
not be identifi ed, and the numbers of participants with 
SA and classic PCD may be greater than reported here. 
Additionally, we did not use immunofl uorescent ciliary 
staining, ciliary beat frequency, or functional ciliary 
analysis in our diagnostic algorithm. Conceivably, these 
techniques may have detected more cases of PCD, and 
we may have excluded PCD cases with normal ciliary 
ultrastructure and genetics but abnormal ciliary func-
tion. Second, the SA control group may not have been a 
pure control group because genetically proven PCD has 
been reported with normal ciliary ultrastructure 34 or 
rarely with normal nNO levels. 35 All SA control partici-
pants were referred for chronic sino-oto-pulmonary 
symptoms, and a healthy SA control group may yield 
diff erent results. Finally, SA control participants were 
signifi cantly younger at study enrollment. Because the 
link between PCD and SA was recently discovered, 
physicians currently managing patients with SA may be 
more attuned to the presence of chronic respiratory 
symptoms in this population. With this knowledge, a 
higher burden of viral infections causing frequent sinus-
itis and otitis in young patients with SA may have 
prompted younger referrals to our consortium. Th is 
age disparity may also account for diff erence in sinopul-
monary symptom prevalence because symptom onset 
may be delayed until an older age. However, this seems 
unlikely, because most patients with classic PCD exhibit 
sinopulmonary symptoms at birth and in the fi rst year 
of life. 
 Conclusions 
 Understanding the potential for PCD in patients with 
laterality defects aside from SI is essential to improve 
clinical outcomes. Year-round wet cough, year-round 
nasal congestion, neonatal respiratory distress, and 
digital clubbing suggest PCD in patients with SA. Any 
patient with these symptoms and laterality defects apart 
from SI should have their respiratory cilia studied. 
Appropriate testing for PCD with SA includes genetic 
testing, nNO measurement, and EM ciliary examination 
at an experienced PCD center. 
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